We recently had the opportunity to sit down with Alex del Priore, Senior VP at Syngene, for a fascinating conversation about their new site acquisition in Baltimore. It was great to hear Alex’s insights on what this means for Syngene, the impact on their operations, capabilities and customers demand.
We really enjoyed discussing the values that drive such strategic decisions and how they align with Syngene’s commitment to innovation and growth. If you’re curious about how companies like Syngene navigate these transformative changes, we invite you to check out the interview!
#syngene #leadership #acquisition #biotechnology #riskMmnagement #businessStrategy #pharmaceuticals